Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anticancer agents or antimetastatic agents using FSTL1 and combination drug thereof

Anticancer agents or antimetastatic agents using FSTL1 and combination drug thereof

US Patent 10806787 · Granted Oct 20, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PAD4 antibody2025
Anti-PAD4 antibody2025
Anti-PAD4 antibody2025
Anti-PAD4 antibody2022
Anti-PAD4 antibody2022
Anti-PAD4 antibody2022
Peptides having osteoblast growth-promoting activity and use thereof2020
Therapeutic drug for malignant tumors2019
Therapeutic drug for malignant tumors2019
Esophageal cancer marker and use thereof2018
Esophageal cancer marker and use thereof2018
Reducer of immunosuppression by tumor cell and antitumor agent using the same2015